Clinical and Pharmacological Characteristics of Patients with Chronic Kidney Failure on Dialysis: A Study at the Dialysis Center of the Municipality of Ariquemes, Brazilian Amazon

The patient with CRF presents, in addition to kidney damage, other pathologies covered that injure the condition, making treatment difficult. The general objective of the study is to analyze the clinical and pharmacological characteristics of patients with Chronic Renal Failure (CRF) on hemodialysis treated at a dialysis unit in the municipality of Ariquemes, state of Rondônia, Brazilian Amazon. Data were collected through two sources: in medical records and in interviews with patients. The research had a random sampling of 30 patients of both sexes. Systolic arterial hypertension (SAH) is the main cause of CRF with 50% of cases, followed by polycystic kidney disease (PRD) 13.3% and diabetes mellitus (DM) 6.7%, systemic lupus erythematosus (SLE) 3, 3% and other diseases with 25.7%. The relative frequency of SAH as the underlying disease (50%), SAH comorbidity (70%), hematocrit alteration (96.7%), anemic corrective P.M. (96.7%), access condition = fistula (93.3%), report of another pathology (73.3%), phosphorus alteration (46.6%) and P.M with phosphorus correction (46.6%) are the main clinical characteristics found. One hundred percent of patients use medications, 80% know what the drugs they use are for, 80% of patients know how to describe medications, 76.6 follow the prescriptions, 50% receive pharmaceutical guidance and 80% say they understand the guidance. The use of 4 to 6 medications a day prevailed (53.3%), 20% practice self-medication, 23.3% use teas and medicinal plants and 96.6 seek medical help when necessary. The results presented show several aspects of the population of patients with chronic renal failure in the Amazon scenario, which will serve to support decisions to improve care for these patients, including the creation and long-term maintenance of a comprehensive data and information recording system with the socioeconomic, clinical and pharmacological characteristics, in addition to the follow-up of patients outside the treatment unit, the analysis and dissemination of epidemiological data on patients with CRF undergoing renal treatment in a Dialysis Center.